MRI/MRS in neuroinflammation: methodology and applications

Clinical and Translational Imaging

Volumn 3, Issue 6, 2015, Pages 475-489

  Quarantelli, Mario ^a  

^a CNR   (Italy)

Author keywords

Magnetic resonance imaging; Magnetic resonance spectroscopy; Neuroinflammation; Superparamagnetic iron oxides

Indexed keywords

CD31 ANTIGEN; CHOLINE; GADOLINIUM PENTETATE; INTERCELLULAR ADHESION MOLECULE 1; IRON OXIDE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; SIALYL LEWIS X ANTIGEN; SUPERPARAMAGNETIC IRON OXIDE; TIGHT JUNCTION PROTEIN;

ALGORITHM; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN ATROPHY; CELL ACTIVATION; CELL ADHESION; CELL COMPARTMENTALIZATION; CELL LABELING; CELL MIGRATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL (TOPIC); DIFFUSION WEIGHTED IMAGING; ENDOTHELIUM CELL; EXTRAVASATION; GLIA CELL; GRAY MATTER; HUMAN; IMMUNOCOMPETENT CELL; INTERSTITIUM; LEUKOCYTE; MEMBRANE PERMEABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 84952995824     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-015-0142-y     Document Type: Review

References (119)

1. Peruzzotti-Jametti L, Donega M, Giusto E, Mallucci G, Marchetti B, Pluchino S (2014) The role of the immune system in central nervous system plasticity after acute injury. Neuroscience 283:210–221. doi:10.1016/j.neuroscience.2014.04.036
2. Jacobs AH, Tavitian B (2012) Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab 32(7):1393–1415. doi:10.1038/jcbfm.2012.53
3. Chiu IM, von Hehn CA, Woolf CJ (2012) Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci 15(8):1063–1067. doi:10.1038/nn.3144
4. Xanthos DN, Sandkuhler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15(1):43–53. doi:10.1038/nrn3617
5. Estes ML, McAllister AK (2014) Alterations in immune cells and mediators in the brain: it’s not always neuroinflammation! Brain Pathol 24(6):623–630. doi:10.1111/bpa.12198
6. Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19(12):1584–1596. doi:10.1038/nm.3407
7. Petty MA, Lo EH (2002) Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 68(5):311–323
8. Takeshita Y, Ransohoff RM (2012) Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol Rev 248(1):228–239. doi:10.1111/j.1600-065X.2012.01127.x
9. Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW (2007) Patterns of contrast enhancement in the brain and meninges. Radiographics 27(2):525–551. doi:10.1148/rg.272065155
10. Jelescu IO, Leppert IR, Narayanan S, Araujo D, Arnold DL, Pike GB (2011) Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magn Reson Imaging 33(6):1291–1300. doi:10.1002/jmri.22565
11. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I (2003) Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74(1):70–76
12. Starr JM, Farrall AJ, Armitage P, McGurn B, Wardlaw J (2009) Blood-brain barrier permeability in Alzheimer’s disease: a case-control MRI study. Psychiatry Res 171(3):232–241. doi:10.1016/j.pscychresns.2008.04.003
13. Elahy M, Jackaman C, Mamo JC, Lam V, Dhaliwal SS, Giles C, Nelson D, Takechi R (2015) Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun Ageing 12:2. doi:10.1186/s12979-015-0029-9
14. Rebeles F, Fink J, Anzai Y, Maravilla KR (2006) Blood-brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging 17(2):107–116. doi:10.1097/RMR.0b013e31802f5df9
15. Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, Haruyama T, Kitajima K, Furui S (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276(1):228–232. doi:10.1148/radiol.2015142690
16. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275(3):772–782. doi:10.1148/radiol.15150025
17. Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Heiland S, Wick W, Schlemmer HP, Bendszus M (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275(3):783–791. doi:10.1148/radiol.2015150337
18. Ramalho J, Castillo M, AlObaidy M, Nunes RH, Ramalho M, Dale BM, Semelka RC (2015) High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents. Radiology 276(3):836–844. doi:10.1148/radiol.2015150872
19. Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B (2005) Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 65(2):280–285. doi:10.1212/01.wnl.0000168837.87351.1f
20. Heye AK, Culling RD, Valdes Hernandez Mdel C, Thrippleton MJ, Wardlaw JM (2014) Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A Systematic review. NeuroImage Clin 6:262–274. doi:10.1016/j.nicl.2014.09.002
21. Sourbron SP, Buckley DL (2013) Classic models for dynamic contrast-enhanced MRI. NMR Biomed 26(8):1004–1027. doi:10.1002/nbm.2940
22. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10(3):223–232
23. St Lawrence KS, Lee TY (1998) An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 18(12):1365–1377. doi:10.1097/00004647-199812000-00011
24. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, Griebel J (2004) Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 52(2):420–429. doi:10.1002/mrm.20161
25. Liu HL, Chang TT, Yan FX, Li CH, Lin YS, Wong AM (2015) Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI. NMR Biomed 28(6):642–649. doi:10.1002/nbm.3297
26. Alliance RQIB (2012) Profile: DCE MRI quantification profile. Version 1.0. Reviewed draft. QIBA. http://www.rsna.org/uploadedFiles/RSNA/Content/Science_and_Education/QIBA/DCE-MRI_Quantification_Profile_v1%200-ReviewedDraft%208-8-12.pdf. Accessed 17 Aug 2015
27. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7(9):678–689. doi:10.1038/nri2156
28. Jung CW, Jacobs P (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13(5):661–674
29. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–2110. doi:10.1021/cr068445e
30. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11(11):2319–2331. doi:10.1007/s003300100908
31. Bjornerud A, Johansson L (2004) The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. NMR Biomed 17(7):465–477. doi:10.1002/nbm.904
32. McAteer MA, Sibson NR, von Zur Muhlen C, Schneider JE, Lowe AS, Warrick N, Channon KM, Anthony DC, Choudhury RP (2007) In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 13(10):1253–1258. doi:10.1038/nm1631
33. Gauberti M, Montagne A, Marcos-Contreras OA, Le Behot A, Maubert E, Vivien D (2013) Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes. Stroke 44(7):1988–1996. doi:10.1161/STROKEAHA.111.000544
34. Hoyte LC, Brooks KJ, Nagel S, Akhtar A, Chen R, Mardiguian S, McAteer MA, Anthony DC, Choudhury RP, Buchan AM, Sibson NR (2010) Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 30(6):1178–1187. doi:10.1038/jcbfm.2009.287
35. Serres S, Mardiguian S, Campbell SJ, McAteer MA, Akhtar A, Krapitchev A, Choudhury RP, Anthony DC, Sibson NR (2011) VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. FASEB J 25(12):4415–4422. doi:10.1096/fj.11-183772
36. Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, Louin G, Buisson A, Haelewyn B, Docagne F, Defer G, Vivien D, Maubert E (2012) Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. NeuroImage 63(2):760–770. doi:10.1016/j.neuroimage.2012.07.018
37. Duffy BA, Choy M, Riegler J, Wells JA, Anthony DC, Scott RC, Lythgoe MF (2012) Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. NeuroImage 60(2):1149–1155. doi:10.1016/j.neuroimage.2012.01.048
38. van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG (2009) Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci USA 106(1):18–23. doi:10.1073/pnas.0806787106
39. Deddens LH, van Tilborg GA, van der Toorn A, van der Marel K, Paulis LE, van Bloois L, Storm G, Strijkers GJ, Mulder WJ, de Vries HE, Dijkhuizen RM (2013) MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent. Mol Imaging Biol 15(4):411–422. doi:10.1007/s11307-013-0617-z
40. Zhu Y, Ling Y, Zhong J, Liu X, Wei K, Huang S (2012) Magnetic resonance imaging of radiation-induced brain injury using targeted microparticles of iron oxide. Acta Radiol 53(7):812–819. doi:10.1258/ar.2012.120040
41. Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM (2005) Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 53(3):621–627. doi:10.1002/mrm.20391
42. Steinman L (2005) Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nat Rev Drug Discov 4(6):510–518. doi:10.1038/nrd1752
43. Prinz M, Priller J (2014) Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15(5):300–312. doi:10.1038/nrn3722
44. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101(30):10901–10906. doi:10.1073/pnas.0403918101
45. Reimer P, Tombach B (1998) Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8(7):1198–1204. doi:10.1007/s003300050535
46. Heyn C, Bowen CV, Rutt BK, Foster PJ (2005) Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med 53(2):312–320. doi:10.1002/mrm.20356
47. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T (2004) Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 36(8):976–984. doi:10.1016/j.freeradbiomed.2004.01.016
48. Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL (2007) Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 243(2):467–474. doi:10.1148/radiol.2432060120
49. Novak ML, Koh TJ (2013) Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol 183(5):1352–1363. doi:10.1016/j.ajpath.2013.06.034
50. Settles M, Etzrodt M, Kosanke K, Schiemann M, Zimmermann A, Meier R, Braren R, Huber A, Rummeny EJ, Weissleder R, Swirski FK, Wildgruber M (2011) Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles. PLoS One 6(10):e25197. doi:10.1371/journal.pone.0025197
51. Siglienti I, Bendszus M, Kleinschnitz C, Stoll G (2006) Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J Neuroimmunol 173(1–2):166–173. doi:10.1016/j.jneuroim.2005.11.011
52. Robinson KM, Njus JM, Phillips DA, Proctor TM, Rooney WD, Jones RE (2010) MR imaging of inflammation during myelin-specific T cell-mediated autoimmune attack in the EAE mouse spinal cord. Mol Imaging Biol 12(3):240–249. doi:10.1007/s11307-009-0272-6
53. Engberink RD, van der Pol SM, Walczak P, van der Toorn A, Viergever MA, Dijkstra CD, Bulte JW, de Vries HE, Blezer EL (2010) Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis. Mol Imaging 9(5):268–277
54. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA (2004) Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 55(5):654–659. doi:10.1002/ana.20066
55. Stroh A, Zimmer C, Werner N, Gertz K, Weir K, Kronenberg G, Steinbrink J, Mueller S, Sieland K, Dirnagl U, Nickenig G, Endres M (2006) Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging. NeuroImage 33(3):886–897. doi:10.1016/j.neuroimage.2006.07.009
56. Richards JM, Shaw CA, Lang NN, Williams MC, Semple SI, MacGillivray TJ, Gray C, Crawford JH, Alam SR, Atkinson AP, Forrest EK, Bienek C, Mills NL, Burdess A, Dhaliwal K, Simpson AJ, Wallace WA, Hill AT, Roddie PH, McKillop G, Connolly TA, Feuerstein GZ, Barclay GR, Turner ML, Newby DE (2012) In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging 5(4):509–517. doi:10.1161/CIRCIMAGING.112.972596
57. Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G (2003) In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J Cereb Blood Flow Metabol 23(11):1356–1361. doi:10.1097/01.WCB.0000090505.76664.DB
58. Tanaka R, Komine-Kobayashi M, Mochizuki H, Yamada M, Furuya T, Migita M, Shimada T, Mizuno Y, Urabe T (2003) Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience 117(3):531–539
59. Rausch M, Baumann D, Neubacher U, Rudin M (2002) In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 15(4):278–283. doi:10.1002/nbm.770
60. Kim J, Kim DI, Lee SK, Kim DJ, Lee JE, Ahn SK (2008) Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology. Acta Radiol 49(5):580–588. doi:10.1080/02841850802020484
61. Wiart M, Davoust N, Pialat JB, Desestret V, Moucharrafie S, Cho TH, Mutin M, Langlois JB, Beuf O, Honnorat J, Nighoghossian N, Berthezene Y (2007) MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke 38(1):131–137. doi:10.1161/01.STR.0000252159.05702.00
62. Muldoon LL, Pagel MA, Kroll RA, Roman-Goldstein S, Jones RS, Neuwelt EA (1999) A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery. AJNR Am J Neuroradiol 20(2):217–222
63. Oude Engberink RD, Blezer EL, Hoff EI, van der Pol SM, van der Toorn A, Dijkhuizen RM, de Vries HE (2008) MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J Cereb Blood Flow Metabol 28(4):841–851. doi:10.1038/sj.jcbfm.9600580
64. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, Jander S (2004) In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127(Pt 7):1670–1677. doi:10.1093/brain/awh191
65. Nighoghossian N, Wiart M, Cakmak S, Berthezene Y, Derex L, Cho TH, Nemoz C, Chapuis F, Tisserand GL, Pialat JB, Trouillas P, Froment JC, Hermier M (2007) Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 38(2):303–307. doi:10.1161/01.STR.0000254548.30258.f2
66. Oude Engberink RD, Blezer EL, Dijkstra CD, van der Pol SM, van der Toorn A, de Vries HE (2010) Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis. NMR Biomed 23(9):1087–1096. doi:10.1002/nbm.1536
67. Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M (2003) MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med 50(2):309–314. doi:10.1002/mrm.10541
68. Dousset V, Ballarino L, Delalande C, Coussemacq M, Canioni P, Petry KG, Caille JM (1999) Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol 20(2):223–227
69. Brochet B, Deloire MS, Touil T, Anne O, Caille JM, Dousset V, Petry KG (2006) Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE. NeuroImage 32(1):266–274. doi:10.1016/j.neuroimage.2006.03.028
70. Vellinga MM, Oude Engberink RD, Seewann A, Pouwels PJ, Wattjes MP, van der Pol SM, Pering C, Polman CH, de Vries HE, Geurts JJ, Barkhof F (2008) Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131(Pt 3):800–807. doi:10.1093/brain/awn009
71. Pirko I, Johnson A, Ciric B, Gamez J, Macura SI, Pease LR, Rodriguez M (2004) In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 18(1):179–182. doi:10.1096/fj.02-1124fje
72. Chen JW, Querol Sans M, Bogdanov A Jr, Weissleder R (2006) Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240(2):473–481. doi:10.1148/radiol.2402050994
73. Querol M, Chen JW, Bogdanov AA Jr (2006) A paramagnetic contrast agent with myeloperoxidase-sensing properties. Org Biomol Chem 4(10):1887–1895. doi:10.1039/b601540a
74. Breckwoldt MO, Chen JW, Stangenberg L, Aikawa E, Rodriguez E, Qiu S, Moskowitz MA, Weissleder R (2008) Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci USA 105(47):18584–18589. doi:10.1073/pnas.0803945105
75. Forghani R, Wojtkiewicz GR, Zhang Y, Seeburg D, Bautz BR, Pulli B, Milewski AR, Atkinson WL, Iwamoto Y, Zhang ER, Etzrodt M, Rodriguez E, Robbins CS, Swirski FK, Weissleder R, Chen JW (2012) Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. Radiology 263(2):451–460. doi:10.1148/radiol.12111593
76. Kleijn A, Chen JW, Buhrman JS, Wojtkiewicz GR, Iwamoto Y, Lamfers ML, Stemmer-Rachamimov AO, Rabkin SD, Weissleder R, Martuza RL, Fulci G (2011) Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging. Clin Cancer Res 17(13):4484–4493. doi:10.1158/1078-0432.CCR-11-0575
77. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H (2001) Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13(4):534–546
78. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G (1996) Diffusion tensor MR imaging of the human brain. Radiology 201(3):637–648. doi:10.1148/radiology.201.3.8939209
79. Conturo TE, McKinstry RC, Akbudak E, Robinson BH (1996) Encoding of anisotropic diffusion with tetrahedral gradients: a general mathematical diffusion formalism and experimental results. Magn Reson Med 35(3):399–412
80. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37(1):13–25. doi:10.1016/j.nbd.2009.07.030
81. Tourdias T, Mori N, Dragonu I, Cassagno N, Boiziau C, Aussudre J, Brochet B, Moonen C, Petry KG, Dousset V (2011) Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation. J Neuroinflamm 8:143. doi:10.1186/1742-2094-8-143
82. Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y (2009) Free water elimination and mapping from diffusion MRI. Magn Reson Med 62(3):717–730. doi:10.1002/mrm.22055
83. Pasternak O, Kubicki M, Shenton ME (2015) In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res. doi:10.1016/j.schres.2015.05.034
84. Pasternak O, Westin CF, Dahlben B, Bouix S, Kubicki M (2015) The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr Res 161(1):113–118. doi:10.1016/j.schres.2014.07.031
85. Pierpaoli C, Barnett A, Pajevic S, Chen R, Penix LR, Virta A, Basser P (2001) Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. NeuroImage 13(6 Pt 1):1174–1185. doi:10.1006/nimg.2001.0765
86. Inglese M, Bester M (2010) Diffusion imaging in multiple sclerosis: research and clinical implications. NMR Biomed 23(7):865–872. doi:10.1002/nbm.1515
87. Henkelman RM, Stanisz GJ, Graham SJ (2001) Magnetization transfer in MRI: a review. NMR Biomed 14(2):57–64
88. Vavasour IM, Laule C, Li DK, Traboulsee AL, MacKay AL (2011) Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imag 33(3):713–718. doi:10.1002/jmri.22441
89. Serres S, Anthony DC, Jiang Y, Broom KA, Campbell SJ, Tyler DJ, van Kasteren SI, Davis BG, Sibson NR (2009) Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neurosci 29(15):4820–4828. doi:10.1523/JNEUROSCI.0406-09.2009
90. Harrison NA, Cooper E, Dowell NG, Keramida G, Voon V, Critchley HD, Cercignani M (2015) Quantitative magnetization transfer imaging as a biomarker for effects of systemic inflammation on the brain. Biol Psychiatry 78(1):49–57. doi:10.1016/j.biopsych.2014.09.023
91. Lovblad KO, Anzalone N, Dorfler A, Essig M, Hurwitz B, Kappos L, Lee SK, Filippi M (2010) MR imaging in multiple sclerosis: review and recommendations for current practice. AJNR Am J Neuroradiol 31(6):983–989. doi:10.3174/ajnr.A1906
92. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15(3–5):289–298
93. Chang L, Munsaka SM, Kraft-Terry S, Ernst T (2013) Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimm Pharmacol 8(3):576–593. doi:10.1007/s11481-013-9460-x
94. Oenarto J, Gorg B, Moos M, Bidmon HJ, Haussinger D (2014) Expression of organic osmolyte transporters in cultured rat astrocytes and rat and human cerebral cortex. Arch Biochem Biophys 560:59–72. doi:10.1016/j.abb.2014.06.024
95. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128(Pt 5):1016–1025. doi:10.1093/brain/awh467
96. Kirov II, Patil V, Babb JS, Rusinek H, Herbert J, Gonen O (2009) MR spectroscopy indicates diffuse multiple sclerosis activity during remission. J Neurol Neurosurg Psychiatry 80(12):1330–1336. doi:10.1136/jnnp.2009.176263
97. Fernando KT, McLean MA, Chard DT, MacManus DG, Dalton CM, Miszkiel KA, Gordon RM, Plant GT, Thompson AJ, Miller DH (2004) Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127(Pt 6):1361–1369. doi:10.1093/brain/awh153
98. Kirov II, Tal A, Babb JS, Herbert J, Gonen O (2013) Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology 80(1):39–46. doi:10.1212/WNL.0b013e31827b1a8c
99. Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Cotton F, Confavreux C, Sappey-Marinier D (2012) Implementation of an absolute brain 1H-MRS quantification method to assess different tissue alterations in multiple sclerosis. IEEE Trans Bio-Med Eng 59(10):2687–2694. doi:10.1109/TBME.2011.2161609
100. Grover VP, Pavese N, Koh SB, Wylezinska M, Saxby BK, Gerhard A, Forton DM, Brooks DJ, Thomas HC, Taylor-Robinson SD (2012) Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat 19(2):e89–e96. doi:10.1111/j.1365-2893.2011.01510.x
101. Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M, Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K (2011) Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut 60(3):370–377. doi:10.1136/gut.2010.217976
102. Bothwell JH, Rae C, Dixon RM, Styles P, Bhakoo KK (2001) Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo. J Neurochem 77(6):1632–1640
103. Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107(5):1475–1480
104. Schweinsburg BC, Taylor MJ, Videen JS, Alhassoon OM, Patterson TL, Grant I (2000) Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. Alcohol Clin Exp Res 24(5):699–705
105. Haley AP, Gonzales MM, Tarumi T, Tanaka H (2013) Dyslipidemia links obesity to early cerebral neurochemical alterations. Obesity (Silver Spring) 21(10):2007–2013. doi:10.1002/oby.20332
106. Gonzales MM, Tarumi T, Eagan DE, Tanaka H, Vaghasia M, Haley AP (2012) Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations. Psychosom Med 74(7):691–698. doi:10.1097/PSY.0b013e31825ff1de
107. Chiappelli J, Hong LE, Wijtenburg SA, Du X, Gaston F, Kochunov P, Rowland LM (2015) Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation. Transl Psychiatry 5:e548. doi:10.1038/tp.2015.43
108. Raininko R, Mattsson P (2010) Metabolite concentrations in supraventricular white matter from teenage to early old age: a short echo time 1H magnetic resonance spectroscopy (MRS) study. Acta Radiol 51(3):309–315. doi:10.3109/02841850903476564
109. Callot V, Galanaud D, Le Fur Y, Confort-Gouny S, Ranjeva JP, Cozzone PJ (2008) (1)H MR spectroscopy of human brain tumours: a practical approach. Eur J Radiol 67(2):268–274. doi:10.1016/j.ejrad.2008.02.036
110. Stuckey DJ, Anthony DC, Lowe JP, Miller J, Palm WM, Styles P, Perry VH, Blamire AM, Sibson NR (2005) Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy. J Leukoc Biol 78(2):393–400. doi:10.1189/jlb.1203604
111. Filibian M, Frasca A, Maggioni D, Micotti E, Vezzani A, Ravizza T (2012) In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 53(11):1907–1916. doi:10.1111/j.1528-1167.2012.03685.x
112. Brooks WM, Stidley CA, Petropoulos H, Jung RE, Weers DC, Friedman SD, Barlow MA, Sibbitt WL Jr, Yeo RA (2000) Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J Neurotrauma 17(8):629–640. doi:10.1089/089771500415382
113. Schuhmann MU, Stiller D, Skardelly M, Bernarding J, Klinge PM, Samii A, Samii M, Brinker T (2003) Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. J Neurotrauma 20(8):725–743. doi:10.1089/089771503767869962
114. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, Ahl B, Manns MP, Boker KW (2004) Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41(5):845–851. doi:10.1016/j.jhep.2004.07.022
115. Narayana PA (2005) Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 15(4 Suppl):46S–57S. doi:10.1177/1051228405284200
116. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405. doi:10.1016/S1474-4422(15)70016-5
117. Reus GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, Kapczinski F, Quevedo J (2015) The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 300:141–154. doi:10.1016/j.neuroscience.2015.05.018
118. Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, Hill E, Hsu S, Izquierdo-Garcia D, Ji RR, Riley M, Wasan AD, Zurcher NR, Albrecht DS, Vangel MG, Rosen BR, Napadow V, Hooker JM (2015) Evidence for brain glial activation in chronic pain patients. Brain 138(Pt 3):604–615. doi:10.1093/brain/awu377
119. Zurcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME, Hooker JM, Atassi N (2015) Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. NeuroImage Clin 7:409–414. doi:10.1016/j.nicl.2015.01.009